Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Efficacy of the Peptide Drug Conjugates Melflufen and OPDC3 in Venetoclax Resistant Acute Myeloid Leukemia

Romika Kumari, Juho J. Miettinen, Mahesh B. Tambe, June Olgac, Tanja Ruokoranta, Nemo Ikonen, Minna H. Suvela, Maiju-Emilia Huppunen, Stefan Svensson Gelius, Klara Acs, Caroline A. Heckman

Blood (2024) 144 (Supplement 1): 1548.

https://doi.org/10.1182/blood-2024-194582

Published: 2024

Journal Articles

Deciphering Variability in Light Chain Amyloidosis and Amyloidosis with Co-Occurring Multiple Myeloma By Single-Cell RNA Sequencing

Ankita Srivastava, Romika Kumari, Juho J. Miettinen, Minna H. Suvela, Klara Acs, Sini Luoma, Caroline A. Heckman

Blood (2024) 144 (Supplement 1): 4648.

https://doi.org/10.1182/blood-2024-209791

Published: 2024

Journal Articles

The Impact of the Peptide Drug Conjugate Melflufen on the Myeloma Tumour Microenvironment

Philipp Sergeev, Juho Jalmari Miettinen, Stefan Svensson Gelius, Klara Acs, Caroline A. Heckman

Blood (2023) 142 (Supplement 1): 5781.

https://doi.org/10.1182/blood-2023-188603

Published: 2023

Journal Articles

The Novel Peptide Drug Conjugate OPDC3 Is Highly Active in Different Hematological Malignancies

Juho J. Miettinen, Tanja Ruokoranta, Vilma Ikonen, Maiju-Emilia Huppunen, Klara Acs, Fredrik Lehmann, Caroline A. Heckman

Blood (2022) 140 (Supplement 1): 10697–10698.

https://doi.org/10.1182/blood-2022-166090

Published: 2022

Journal Articles

A Potential Role of NK Cells and ABCB9 in Modulating the Response to Melflufen in Multiple Myeloma

Philipp Sergeev, Sadiksha Adhikari, Juho J. Miettinen, Maiju-Emilia Huppunen, Minna Suvela, Ana Slipicevic, Nina N. Nupponen, Klara Acs, Fredrik Lehmann, Caroline A. Heckman

Blood (2022) 140 (Supplement 1): 6000–6001.

https://doi.org/10.1182/blood-2022-162182

Published: 2022